In today’s briefing:
- APAC Healthcare Weekly (Oct 13)- CSPC Pharma, Hugel, Astellas, Ono Pharma, and Hanmi Pharm
- Japan Weekly | Record Highs; Nikon, Konami, Money Forward Outperform
APAC Healthcare Weekly (Oct 13)- CSPC Pharma, Hugel, Astellas, Ono Pharma, and Hanmi Pharm
- CSPC Pharmaceutical entered into an exclusive license agreement with AstraZeneca for the global development, manufacture, and commercialization bad cholesterol lowering drug candidate YS2302018.
- Ono Pharmaceutical entered into a license agreement with LigaChem Biosciences for LCB97, a pre-clinical stage antibody-drug conjugate (ADC) aimed at being a first-in-class drug in the field of solid tumors.
- The U.S. International Trade Commission (ITC) has issued final ruling in favor of Hugel. This should accelerate Hugel’s business expansion in the U.S.
Japan Weekly | Record Highs; Nikon, Konami, Money Forward Outperform
- Resilient macro data fueled an all-time high for the S&P 500 (+1.1% week-on-week), suggesting continued optimism in the market.
- In Japan, equities performed well with the Nikkei +2.5% and Topix +0.5% higher as earnings remained supportive.
- With earnings reports from major companies like ASML, DISCO, and TSMC approaching, semiconductor stocks may dictate overall market moves next week.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
